Humatrix
Latest round
- Series A
Last raised
- Jun 2026
Total raised
- $14M
Investors
- 8
About Humatrix
, trading as Humatrix, operates as a medicine technology developer that engages in the research and development of tissue engineering and regenerative medicine technology platforms. The company's founder, Xuefeng Qiu, is a member of the American Society for Biomedical Engineering and the Cardiovascular Surgery Branch of the Chinese Medical Association. The company provides a tissue engineering and regenerative medicine technology platform. The core product pipeline is a small-caliber (inner diameter = 6 mm) tissue-engineering blood vessel that is suitable for the establishment of vascular access for chronic renal failure dialysis, vascular replacement for lower extremity arterial trauma, lower extremity atherosclerosis, and coronary heart disease bypass surgery. Its products include allogeneic regenerative medicine products, such as tissue-engineered ureters, tissue-engineered heart valves, nerve repair catheters, and decellularized tissues and organs. The company generates revenue through the development and manufacture of artificial organ-based pharmaceutical products.
Who invested in Humatrix
8 investors across 4 rounds
See all investors in Humatrix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Humatrix
Who invested in Humatrix?
Humatrix has 8 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Humatrix raised?
Humatrix has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Humatrix last raise money?
Humatrix's most recent round on record is a Series A, in Jun 2026.
What does Humatrix do?
, trading as Humatrix, operates as a medicine technology developer that engages in the research and development of tissue engineering and regenerative medicine technology platforms.
Where is Humatrix headquartered?
Humatrix is headquartered in Suzhou, China.
Which VCs invest in companies like Humatrix?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Humatrix's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Humatrix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.